EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische Übersicht

Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis

Fardis Vosoughi, Diako Seyedi, Parnian Rahnama, Farhad Shaker, Masoud Imani, Iman Menbari Oskouie

The Knee · 2026-08 · 61 · 104443

DOI: 10.1016/j.knee.2026.104443 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Knee, 2026-08. Verfasst von Fardis Vosoughi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Trauma Surgery, Shariati Hospital, Tehran University Of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antibiotic Prophylaxis, Arthroplasty, Replacement, Knee, Prosthesis-Related Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Periprosthetic joint infection (PJI) remains a challenging complication in total joint arthroplasty (TJA), and concerns about antimicrobial resistance in intravenous (IV) vancomycin have renewed interest in intraosseous (IO) prophylaxis. This meta-analysis compares IO vancomycin versus IV prophylaxis in TJA with respect to overall and time-stratified PJI, organism-specific infections, wound complications, revision rates, pharmacokinetics, acute kidney injury (AKI), and deep vein thrombosis (DVT). METHODS: A systematic review and meta-analysis were conducted, including clinical studies of adults undergoing total knee arthroplasty (TKA) or total hip arthroplasty (THA) that compared IO vancomycin with alternative IV methods. Outcomes were pooled using random-effects models and stratified by follow up intervals (30 days, 90 days, and 1 year). RESULTS: Of the 13 included studies, 12 investigated TKA, comprising 6876 cases (51.6% IO group). Vancomycin concentration was significantly higher in IO group in both femoral bone and fat tissue (standardized mean difference (SMD): 0.61, 95% confidence interval (CI): 0.09-1.12; SMD: 1.53, 95% CI: 0.43-2.62, respectively). Regarding primary TKA cases, IO administration significantly reduced overall PJI (risk ratio (RR): 0.35, 95% CI: 0.17-0.72), with consistent significance at 30-day and 1-year follow up. Gram-positive infections decreased significantly (RR: 0.37, 95% CI: 0.17-0.82), whereas Gram-negative infections were comparable. Non-operative wound complications were significantly lower (RR: 0.50, 95% CI: 0.32-0.80). However, reoperation-requiring wound complications, AKI, DVT, or revision rates were comparable. Regarding revision TKA, the IO group demonstrated a significantly lower rate of non-operative wound complications (RR: 0.23) and a favorable but nonsignificant reduction in PJI. CONCLUSIONS: IO vancomycin prophylaxis provides substantially higher local antibiotic concentrations, lower rates of PJI and superficial wound complications without increasing renal, thrombotic, and revision risk in primary TKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntibiotic ProphylaxisArthroplasty, Replacement, KneeProsthesis-Related InfectionsVancomycinHumansInfusions, Intraosseous

Stichwörter der Autor:innen

Intraosseous vancomycinIntravenous antibiotic prophylaxisPeriprosthetic joint infectionTotal knee arthroplasty

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Department of Orthopaedics and Trauma Surgery, Shariati Hospital, Tehran University Of Medical Sciences, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: farhadshaker780@gmail.com.
  • Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Vosoughi, F., Seyedi, D., Rahnama, P., Shaker, F., Imani, M., & Oskouie, I. M. (2026). Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis. The Knee, 61, 104443. https://doi.org/10.1016/j.knee.2026.104443

Vancouver

Vosoughi F, Seyedi D, Rahnama P, Shaker F, Imani M, Oskouie IM. Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis. The Knee. 2026;61:104443. doi:10.1016/j.knee.2026.104443

BibTeX
@article{Vosoughi2026,
  author = {Vosoughi, Fardis and Seyedi, Diako and Rahnama, Parnian and Shaker, Farhad and Imani, Masoud and Oskouie, Iman Menbari},
  title = {Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis},
  journal = {The Knee},
  year = {2026},
  volume = {61},
  pages = {104443},
  doi = {10.1016/j.knee.2026.104443}
}
Kostenlos starten →